Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of the HemoModulator System for the Treatment of Patients With Human Immunodeficiency Virus (HIV)

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Energex Systems, Inc.
ClinicalTrials.gov Identifier:
NCT00858923
First received: March 6, 2009
Last updated: April 7, 2009
Last verified: March 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: November 2009
  Estimated Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)